Labshake search
Citations for TriLink BioTechnologies :
1 - 8 of 8 citations for Mouse Anti Norovirus GI Antibody NP28 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2023Quote: dAbs were generated by conjugating amine-modified oligonucleotides (15–25 OD260 units) to polyclonal antibodies (100 µg) using the Antibody-Oligonucleotide All-in-One Conjugation Kit from TriLink Biotechnologies (A-9202) ...
-
bioRxiv - Bioengineering 2020Quote: ... R-PE antibody conjugation kit was obtained from TriLink Biotechnologies ...
-
bioRxiv - Immunology 2019Quote: ... Mouse C57BL/6 zygotes (Taconic) were injected with a mix of Cas9 mRNA (Trilink Biotechnologies) (100 ng/uL ...
-
bioRxiv - Synthetic Biology 2021Quote: ... 6 mM Anti Reverse Cap Analog (TriLink BioTechnologies), and the template DNA ...
-
bioRxiv - Immunology 2022Quote: ... including an Anti-Reverse Cap Analog (ARCA, Trilink BioTechnologies), and chemically modified N1-methylpseudouridine-5’-triphosphate (Trilink BioTechnologies ...
-
bioRxiv - Immunology 2020Quote: ... Anti-Reverse Cap Analog (ARCA, Trilink Biotechnologies, San Diego, USA) was used for mRNA capping ...
-
bioRxiv - Cancer Biology 2022Quote: ... carrier-free monoclonal and polyclonal antibodies (Table S2) were conjugated to short DNA oligonucleotides (Trilink Biotechnologies) as described before [4 ...
-
bioRxiv - Immunology 2023Quote: ... an anti-reverse capping analogue (Trilink Biotechnologies, San Diego, CA, USA), N1-methylpseudouridine (Sapala Organics Private Limited ...